Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Neurovascular Devices / Interventional Neurology Market Forecast 2021-2028

Published by Inkwood Research Product code 1018655
Published Content info 212 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Neurovascular Devices / Interventional Neurology Market Forecast 2021-2028
Published: July 19, 2021 Content info: 212 Pages
Description

KEY FINDINGS

The global neurovascular devices / interventional neurology market is projected to grow at a CAGR of 5.08% during the forecast period, 2021-2028. The growing elderly population, prevalence of neurovascular diseases, neurological diseases, and demand for minimally invasive procedures propel the market growth.

MARKET INSIGHTS

Neurovascular devices include coil assist stents, flow diversion stents, embolic coils, clippings, etc. They are used to treat disorders related to blood vessels. For example, the complex forms of aneurysms are treated using coated coils. The growing incidence of neurovascular conditions drives the market growth. Neurovascular systems primarily depend on the continuous supply of oxygen and nutrients carried by veins and arteries. The oxygen and nutrients supply is vital for its working. A defect in the system can hinder its function, thereby becoming a life-threatening factor. Neurovascular conditions, disorders, or diseases include brain aneurysm, brain tumors, vascular malformation, hemorrhage, stroke, etc. The estimated causes of neurovascular diseases are genetic disorders, related chronic diseases, and lifestyle habits.

One of the neurovascular diseases significantly prevalent across the world is the cerebral aneurysm. It is also known as an intracranial aneurysm. It is a bulging area of the brain artery. The bulging further results in abnormal widening. With the presence of a weak spot in the aneurysm wall, there is a risk of rupture of aneurysm bursting. The most common type of cerebral aneurysm is a saccular aneurysm. It occurs in 90% of cerebral aneurysms. However, the lack of an adequate number of trained neurosurgeons and the exorbitant cost of neurovascular devices hamper the market growth.

REGIONAL INSIGHTS

The global neurovascular devices / interventional neurology market growth evaluation includes the analysis of North America, Asia-Pacific, Europe, and Rest of World. North America is the major region in the global market with the rising incidence of neurovascular diseases, surging aging population, and product developments.

COMPETITIVE INSIGHTS

The competitive rivalry is estimated to be high given the growing number of mergers & acquisitions and products launched by major market players. Some prominent market players include Johnson & Johnson (Cerenovus), B Braun Melsungen AG, Integer Holdings Corporation, Microport Scientific Corporation, Acandis GmbH, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 38566

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. INCIDENCE OF NEUROVASCULAR CONDITIONS
    • 3.1.2. DEMAND FOR MINIMALLY INVASIVE PROCEDURES
    • 3.1.3. SIGNIFICANCE OF NEUROLOGICAL DISEASES IN GERIATRIC POPULATION
    • 3.1.4. PREVALENCE OF UNDERLYING DISEASE CONDITIONS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. EXORBITANT COST OF NEUROVASCULAR DEVICES
    • 3.2.2. LACK OF ADEQUATE NUMBER OF TRAINED NEUROSURGEONS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRY
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY PRODUCT

  • 5.1. EMBOLIZATION DEVICES
    • 5.1.1. EMBOLIC COILS
      • 5.1.1.1. COATED DETACHABLE COILS
      • 5.1.1.2. BARE DETACHABLE COILS
    • 5.1.2. COIL ASSIST STENT
    • 5.1.3. CLIPPINGS
    • 5.1.4. COIL ASSIST BALLOON
  • 5.2. ACCESSORY DEVICES
    • 5.2.1. MICROCATHETERS
    • 5.2.2. MICRO GUIDEWIRES
  • 5.3. REVASCULARIZATION DEVICES
    • 5.3.1. CAROTID ARTERY STENTS
    • 5.3.2. FLOW DIVERSION STENTS
  • 5.4. THROMBECTOMY DEVICES
    • 5.4.1. CLOT RETRIEVAL DEVICES
    • 5.4.2. SUCTION AND ASPIRATION DEVICES
    • 5.4.3. SNARES
  • 5.5. EMBOLIC PROTECTION DEVICES
    • 5.5.1. BALLOON OCCLUSION DEVICES
    • 5.5.2. DISTAL FILTER DEVICES

6. MARKET BY APPLICATION

  • 6.1. ANEURYSM
  • 6.2. ISCHEMIC STROKE
  • 6.3. STENOSIS
  • 6.4. ARTERIOVENOUS MALFORMATION (AVM)
  • 6.5. OTHER APPLICATIONS

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. MARKET SIZE & ESTIMATES
    • 7.1.2. KEY GROWTH ENABLERS
    • 7.1.3. KEY CHALLENGES
    • 7.1.4. KEY PLAYERS
    • 7.1.5. COUNTRY ANALYSIS
      • 7.1.5.1. UNITED STATES
      • 7.1.5.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. MARKET SIZE & ESTIMATES
    • 7.2.2. KEY GROWTH ENABLERS
    • 7.2.3. KEY CHALLENGES
    • 7.2.4. KEY PLAYERS
    • 7.2.5. COUNTRY ANALYSIS
      • 7.2.5.1. GERMANY
      • 7.2.5.2. UNITED KINGDOM
      • 7.2.5.3. FRANCE
      • 7.2.5.4. ITALY
      • 7.2.5.5. RUSSIA
      • 7.2.5.6. POLAND
      • 7.2.5.7. BELGIUM
      • 7.2.5.8. REST OF EUROPE
  • 7.3. ASIA-PACIFIC
    • 7.3.1. MARKET SIZE & ESTIMATES
    • 7.3.2. KEY GROWTH ENABLERS
    • 7.3.3. KEY CHALLENGES
    • 7.3.4. KEY PLAYERS
    • 7.3.5. COUNTRY ANALYSIS
      • 7.3.5.1. CHINA
      • 7.3.5.2. JAPAN
      • 7.3.5.3. AUSTRALIA & NEW ZEALAND
      • 7.3.5.4. INDIA
      • 7.3.5.5. SOUTH KOREA
      • 7.3.5.6. THAILAND
      • 7.3.5.7. INDONESIA
      • 7.3.5.8. VIETNAM
      • 7.3.5.9. REST OF ASIA-PACIFIC
  • 7.4. REST OF WORLD
    • 7.4.1. MARKET SIZE & ESTIMATES
    • 7.4.2. KEY GROWTH ENABLERS
    • 7.4.3. KEY CHALLENGES
    • 7.4.4. KEY PLAYERS
    • 7.4.5. REGIONAL ANALYSIS
      • 7.4.5.1. LATIN AMERICA
      • 7.4.5.2. MIDDLE EAST & AFRICA

8. COMPETITIVE LANDSCAPE

  • 8.1. KEY STRATEGIC DEVELOPMENTS
    • 8.1.1. MERGERS & ACQUISITIONS
    • 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 8.1.3. PARTNERSHIPS & AGREEMENTS
    • 8.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
  • 8.2. COMPANY PROFILES
    • 8.2.1. ACANDIS GMBH
    • 8.2.2. ASAHI INTECC
    • 8.2.3. BALT USA LLC
    • 8.2.4. B BRAUN MELSUNGEN AG
    • 8.2.5. INTEGER HOLDINGS CORPORATION
    • 8.2.6. JOHNSON & JOHNSON (CERENOVUS)
    • 8.2.7. KANEKA CORPORATION
    • 8.2.8. MEDTRONIC INC
    • 8.2.9. MEMRY CORPORATION
    • 8.2.10. MICROPORT SCIENTIFIC CORPORATION
    • 8.2.11. PENUMBRA INC
    • 8.2.12. PHENOX GMBH
    • 8.2.13. RAPID MEDICAL
    • 8.2.14. SENSOME
    • 8.2.15. STRYKER CORPORATION
    • 8.2.16. TERUMO MEDICAL CORPORATION (MICROVENTION INC)

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - NEUROVASCULAR DEVICES
  • TABLE 2: GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL EMBOLIZATION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: GLOBAL EMBOLIZATION DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL EMBOLIZATION DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: GLOBAL EMBOLIZATION DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL EMBOLIC COILS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: GLOBAL EMBOLIC COILS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL ACCESSORY DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: GLOBAL ACCESSORY DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL ACCESSORY DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: GLOBAL ACCESSORY DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL REVASCULARIZATION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: GLOBAL REVASCULARIZATION DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL REVASCULARIZATION DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 17: GLOBAL REVASCULARIZATION DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL THROMBECTOMY DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 19: GLOBAL THROMBECTOMY DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL THROMBECTOMY DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 21: GLOBAL THROMBECTOMY DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 23: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 25: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL NEUROVASCULAR DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 27: GLOBAL NEUROVASCULAR DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL ANEURYSM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 29: GLOBAL ANEURYSM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL ISCHEMIC STROKE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 31: GLOBAL ISCHEMIC STROKE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL STENOSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 33: GLOBAL STENOSIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL ARTERIOVENOUS MALFORMATION (AVM) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 35: GLOBAL ARTERIOVENOUS MALFORMATION (AVM) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 37: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL NEUROVASCULAR DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 39: GLOBAL NEUROVASCULAR DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 40: NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 41: NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 42: LEADING PLAYERS OPERATING IN THE NORTH AMERICA NEUROVASCULAR DEVICES MARKET
  • TABLE 43: EUROPE NEUROVASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 44: EUROPE NEUROVASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 45: LEADING PLAYERS OPERATING IN EUROPE NEUROVASCULAR DEVICES MARKET
  • TABLE 46: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 47: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 48: LEADING PLAYERS OPERATING IN ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET
  • TABLE 49: REST OF WORLD NEUROVASCULAR DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 50: REST OF WORLD NEUROVASCULAR DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 51: LEADING PLAYERS OPERATING IN REST OF WORLD NEUROVASCULAR DEVICES MARKET
  • TABLE 52: LIST OF MERGERS & ACQUISITIONS
  • TABLE 53: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 54: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 55: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT, IN 2020
  • FIGURE 6: GLOBAL NEUROVASCULAR DEVICES MARKET, BY EMBOLIZATION DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, 2021-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL EMBOLIC COILS MARKET, BY COATED DETACHABLE COILS, 2021-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL EMBOLIC COILS MARKET, BY BARE DETACHABLE COILS, 2021-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL EMBOLIZATION DEVICES MARKET, BY COIL ASSIST STENT, 2021-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL EMBOLIZATION DEVICES MARKET, BY CLIPPINGS, 2021-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL EMBOLIZATION DEVICES MARKET, BY COIL ASSIST BALLOON, 2021-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL NEUROVASCULAR DEVICES MARKET, BY ACCESSORY DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL ACCESSORY DEVICES MARKET, BY MICROCATHETERS, 2021-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL ACCESSORY DEVICES MARKET, BY MICRO GUIDEWIRES, 2021-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL NEUROVASCULAR DEVICES MARKET, BY REVASCULARIZATION DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL REVASCULARIZATION DEVICES MARKET, BY CAROTID ARTERY STENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL REVASCULARIZATION DEVICES MARKET, BY FLOW DIVERSION STENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL NEUROVASCULAR DEVICES MARKET, BY THROMBECTOMY DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL THROMBECTOMY DEVICES MARKET, BY CLOT RETRIEVAL DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL THROMBECTOMY DEVICES MARKET, BY SUCTION AND ASPIRATION DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL THROMBECTOMY DEVICES MARKET, BY SNARES, 2021-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY BALLOON OCCLUSION DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL THROMBECTOMY DEVICES MARKET, BY DISTAL FILTER DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL NEUROVASCULAR DEVICES MARKET, BY APPLICATION, IN 2020
  • FIGURE 27: GLOBAL NEUROVASCULAR DEVICES MARKET, BY ANEURYSM, 2021-2028 (IN $ MILLION)
  • FIGURE 28: GLOBAL NEUROVASCULAR DEVICES MARKET, BY ISCHEMIC STROKE, 2021-2028 (IN $ MILLION)
  • FIGURE 29: GLOBAL NEUROVASCULAR DEVICES MARKET, BY STENOSIS, 2021-2028 (IN $ MILLION)
  • FIGURE 30: GLOBAL NEUROVASCULAR DEVICES MARKET, BY ARTERIOVENOUS MALFORMATION (AVM), 2021-2028 (IN $ MILLION)
  • FIGURE 31: GLOBAL NEUROVASCULAR DEVICES MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 32: NORTH AMERICA NEUROVASCULAR DEVICES MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 33: UNITED STATES NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 34: CANADA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 35: EUROPE NEUROVASCULAR DEVICES MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 36: GERMANY NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 37: UNITED KINGDOM NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 38: FRANCE NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 39: ITALY NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 40: RUSSIA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 41: POLAND NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 42: BELGIUM NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 43: REST OF EUROPE NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 44: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 45: CHINA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 46: JAPAN NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 47: AUSTRALIA & NEW ZEALAND NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 48: INDIA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 49: SOUTH KOREA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 50: THAILAND NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 51: INDONESIA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 52: VIETNAM NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 53: REST OF ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 54: REST OF WORLD NEUROVASCULAR DEVICES MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 55: LATIN AMERICA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 56: MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
Back to Top